Kumiko Kato, Ph. D.

Kato joined the company in 2011 and has over ten years of experience researching gut bacteria. She has conducted clinical trials evaluating the functionality of probiotic and postbiotic materials, and she currently manages multiple clinical trials. Kato now works at the Functional Foods Research Institute, where she is passionately engaged in clinical research that contributes to the domestic and international development of bacterial materials.

Marc Frischen

As head of Logistics Engineering I am responsible for Network Design & Flow Optimization, M&A Logistics stream, Master Data Management and strategic projects within the overall global logistics transformation.

In SANOFI we are leading a big transformation program for Global Logistics in which we are concentrating on Digitalization and AI road map, Externalization (4PL, 3PL projcts), Logistics Control Tower implementation and Distribution Footprint optimization

Dr Bernd Steffens

Bernd Steffens is currently IU Sustainability Lead Clinical Trials, at Boehringer Ingelheim, based in Biberach, Germany. His ambition is to contribute to the understanding of environmental impact aspects in clinical trials and their decarbonization. Before that he was for about 30 years Head of the Global Clinical Trial Supplies Unit or related functions in the same company, with focus on Supply Chain Management in general, outsourcing strategies, smart global distribution strategies and digitalization initiatives.

He is chemist by profession with diploma and PhD from the Ruhr-Universitaet Bochum and started in industry with process development in API manufacture.

Ilaria Rondinone

Ilaria Rondinone is a Clinical Supply Digital & Technology Lead with strong expertise in driving digital transformation across R&D functions. With more than 14 years of experience in clinical supply, clinical operations, she leads strategic initiatives that integrate advanced technologies—such as AI models, smart patient sensors, and track‑and‑trace solutions—to enhance patient-centric clinical trials.

Throughout her career at Chiesi, she has spearheaded innovative approaches including decentralized clinical trial elements and predictive supply models to reduce waste and improve operational efficiency. Her background spans global clinical supply leadership, digital innovation programs, and cross-functional roles bridging clinical, CMC.

Ilaria holds a degree in Pharmaceutical Chemistry and Technology from the University of Parma, a Master in Pharmaceutical Marketing and Management, a Master in Clinical Research Associate and a European Course in Pharmaceutical Medicine (ECPM) from the University of Basel.

 

Elena Velasco

Clinical Supply Chain Specialist at mAbxience (Madrid, Spain), Master in Neuroscience.

In this role, she is working within the Clinical Team as well as different international service providers to support the execution of the operational flow, ensuring streamlined drug supply throughout the clinical studies delivering on time, within budget, and of high quality in compliance with ICH/GCP, Regulatory Authorities regulations/guidelines, and applicable Standard Operating Procedures.

For almost a year in mAbxience, in conjunction with her previous role in Immutep since 2019, she brings a wealth of experience in clinical trial supply management, vendor oversight and operational excellence.

Her expertise covers supporting clinical study teams from start up to completion, working with CROs, CMOs and several logistic stakeholders in a very international environment (10 years abroad in between Germany and France), ensuring meeting program timelines with the highest standards of quality and efficiency.

Alpesh Doshi

A founding partner of Redcliffe Capital, the firm specializes in investing in and building companies that help enterprises and entrepreneurs leverage innovation in technology such as digital transformation, , Data and Artificial Intelligence. Redcliffe’s investment thesis focuses on the AI First Everything approach. A fundamental change in businesses will emerge in the coming years and provide significant opportunities in every industry.

Alpesh’s career started over 25 years ago after graduating in Computer Science and he now works helping enterprises innovate and implement new technology and business models. He believes that technology tied with business change can transform an enterprise or an industry. He works in the financial services, insurance, energy, telecoms and media and entertainment sectors.

Olaf Larsen

Olaf Larsen studied chemistry and obtained a PhD in physics at the Free University in Amsterdam. After postdoctoral work in New York City and Amsterdam, he continued his career in industry. Olaf worked for ASML, TNO, as consultant life sciences, and headed the science department for Yakult Netherlands for more than 12 years. Next to this, he acts as Asst. Professor for the Free University in Amsterdam. Since September 2025, he is heading research for Ausnutria in The Netherlands.

Jack Cuthbertson

Jack Cuthbertson, MSc, is a Senior Oncology and Hematology Analyst based in London, UK. His core responsibilities include providing in-depth analyses and market intelligence, as well as forecasting the markets of oncology indications, and covering high-profile oncology congresses. Jack has been part of the oncology and hematology team for more than two years. Prior to his current role, he was working on the development of non-viral DNA vectors for gene therapy and biopharmaceutical manufacturing. Jack has an MSc in Synthetic Biology and a BSc in Biochemistry from Newcastle University.

Martin Waroquiers

Martin is a Strategic Account Manager at N-SIDE with 10+ years of experience in the industry, combining planning experience both on the commercial and clinical sides of the supply chain.

Everett Rogers

With over two decades of experience at the intersection of clinical systems and operational strategy, Everett is a veteran in global drug development and eClinical technology. Currently a Global Team Lead at Medidata Solutions, he specializes in Randomization and Trial Supply Management (RTSM). He is particularly passionate about optimizing RTSM operational dashboards with a supply focus to accelerate actionable insights and is dedicated to simplifying clinical data workflows through automated data integration and transformation.